Featured

The role of imaging in transcatheter treatment for tricuspid valve disease



Published
Alex Sticchi, interventional cardiologist, interviews Rebecca Hahn, Interventional Echocardiographer about a recent State of the Art article about transcatheter treatment for tricuspid valve disease published in EuroIntervention.
They discuss the importance of starting with the classification of anatomy and that of secondary TR and why recognising disease severity is a challenge, as well as identifying how clinical cardiolologists can recognise severity via TTE as first-level before a multimodality imaging approach. RV assessment is another essential parameter in the evaluation of patients - is TAPSE/SPAP currently the most trustable value for determining it? And could we hypothesize to extend it to other interventions as a prognostic predictor? Device selection is a very interesting theme, and preprocedural CCT is mandatory besides 3D TEE. In conclusion, Rebecca Hahn shares her perspective about patient eligibility in Tricuspid intervention, repair and replacement in the future!

Read this State of the Art article here
https://eurointervention.pcronline.com/article/transcatheter-treatment-for-tricuspid-valve-disease
EuroIntervention 2021;17:791-808. DOI: 10.4244/EIJ-D-21-00695

View more content from the PCR Tricuspid Focus Group here
https://www.pcronline.com/Cases-resources-images/Zoom-on/Tricuspid-Focus-Group-Content
Category
Health
Be the first to comment